SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $405,578 | -49.2% | 676,189 | +10.2% | 0.00% | -50.0% |
Q2 2023 | $797,842 | -13.7% | 613,724 | +16.8% | 0.00% | 0.0% |
Q1 2023 | $924,493 | -40.8% | 525,280 | +5.6% | 0.00% | -50.0% |
Q4 2022 | $1,561,541 | -49.9% | 497,306 | -21.8% | 0.00% | -50.0% |
Q3 2022 | $3,115,000 | +35.9% | 635,794 | +14.8% | 0.01% | +33.3% |
Q2 2022 | $2,292,000 | -48.7% | 553,727 | -28.0% | 0.01% | +20.0% |
Q1 2022 | $4,466,000 | +30.8% | 768,786 | +68.9% | 0.01% | -28.6% |
Q4 2021 | $3,415,000 | +5.4% | 455,277 | +26.6% | 0.01% | -12.5% |
Q3 2021 | $3,240,000 | -10.7% | 359,678 | +18.7% | 0.01% | -20.0% |
Q2 2021 | $3,628,000 | +10.1% | 303,102 | +15.2% | 0.01% | -9.1% |
Q1 2021 | $3,296,000 | +46.9% | 263,002 | +82.9% | 0.01% | +37.5% |
Q4 2020 | $2,244,000 | +114.5% | 143,834 | +29.9% | 0.01% | +60.0% |
Q3 2020 | $1,046,000 | +55.7% | 110,715 | +47.7% | 0.01% | +25.0% |
Q2 2020 | $672,000 | +119.6% | 74,968 | +56.0% | 0.00% | +100.0% |
Q1 2020 | $306,000 | -14.5% | 48,066 | +12.3% | 0.00% | 0.0% |
Q4 2019 | $358,000 | +21.8% | 42,809 | +31.7% | 0.00% | 0.0% |
Q3 2019 | $294,000 | – | 32,497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |